Acting on insulin
Tuesday, 11 November, 2008
A PhD student from the Garvan Institute in Sydney has discovered a novel action for insulin, describing a new role in glucose uptake.
Freddy Yip and colleagues from the Garvan’s diabetes and obesity research program have found that a member of the myosin motor protein family, 1c, undergoes increased phosphorylation in response to insulin.
Myo1c is thought to play a role in delivering the glucose transporter GLUT4 to the plasma membrane in fat cells.
For people with type 2 diabetes, the team believes there may be blockages in the signal between insulin and Myo1c, perhaps leading to insulin resistance.
The research is published in the November 5 issue of Cell Metabolism [doi:10.1016/j.cmet.2008.09.011].
Scientists 'reprogram' tumour-supporting immune cells
The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...
Existing medicines could help treat deadly childhood dementia
Australian researchers have identified several existing TGA‑approved medicines that could help...
Statins reduce heart attack and stroke risk in older people
It has previously been unclear whether statins were effective in reducing heart attack and stroke...
